Название документа

Pharmacological properties

Protivogelmintny broad-spectrum agent.

Pharmacodynamics. Pyrantelum pamoat is antikholinesterazny means.

Depolarizing effect of Pyrantelum breaks synoptic transfer in a body of helminths (in the beginning strengthens it, then oppresses), leads to development of neuromuscular blockade and thereof — to spastic paralysis of muscles of helminths, promoting their removal with a stake. Affects both puberal, and immature individuals of the helminths sensitive to drug, does not work on larvae in a migration stage.

Pharmacokinetics. Practically it is not soaked up in a digestive tract (3.5%). After single dose of medicament in a dose of 10 mg/kg of body weight the concentration of Pyrantelum in blood plasma is insignificant — 0.05-0.13 mg/ml during 1–3 h. After absorption in the system of blood it is partially metabolized in a liver. The main metabolite — N-methyl-1-3-propandiamin which about 1.2-4.6% are removed with urine. More than 93% of Pyrantelum are removed in not changed view with a stake.

Indication

Treatment of helminthoses: ascaridosis, enterobiosis, dochmiasis, necatoriasis, trikhostrongillez.

Use

by

is Appointed inside for 1 reception at any time; there is no need to abstain from meal or to accept depletive before Pyrantelum use.

In an enterobiosis and a combination of an enterobiosis with an ascaridosis to adults and children medicament is appointed in one stage in a dose of 10 mg/kg of body weight or according to the following scheme:

Age a medicament Dose
Children of 3-6 years 250 mg 1 tablet
Children of 6-12 years 500 mg 2 tablets
Children are more senior than 12 years and adults with the body weight of 75 kg 750 mg 3 tablets
Adult 1000 mg 4 tablets

At severe forms of a disease appoint a double dose — 20 mg/kg/days in 1–2 receptions within 2–3 days.

to

For prevention of autoinvasion recommended repeated intake of Pyrantelum in 3 weeks in a dose of 10 mg/kg of body weight.

At the isolated ascaridosis — 5 mg/kg/days are one-stage.

In a dochmiasis, a necatoriasis, a necatoriasis combination with an ascaridosis or at other combined gelmintny invasions medicament is used in a dose 10 mg/kg/days within 3 days or 20 mg/kg/days within 2 days.

to Children under 3 years medicament is appointed in the form of suspension for oral administration.

Contraindication

Hypersensitivity to drug; liver failure.

Side effects

Drug is usually well transferred by

.

following side reactions Are possible

:

from a GIT: pain in epigastric area, nausea, vomiting, diarrhea, anorexia; spasms in a stomach, tenesmus.

from a gepatobiliarny system: increase in activity of hepatic transaminases.

Neurologic disorders: headache, dizziness, drowsiness, increased fatigue, insomnia, weakness.

from skin and hypodermic cellulose: skin rashes, itching, small tortoiseshell.

to

Special instructions

by

Before the use of Pyrantelum does not need special preparation and intake of depletive.

Tablet before swallowing needs to be chewed carefully.

carry out by

In an enterobiosis simultaneous treatment of all persons living together.

to

For achievement of effect at treatment of an enterobiosis needs strict observance of rules of personal hygiene, first of all children and also repeated intake of Pyrantelum in 3 weeks.

After end of a course of treatment conduct a control research a calla on existence of eggs of helminths.

Period of pregnancy and feeding by a breast. In pilot studies of teratogenic effect of Pyrantelum it is not revealed, during pregnancy and feeding by a breast medicament is used after careful assessment of a ratio advantage for woman/risk for a fruit (child) which is defined by the doctor and strictly adhere to the recommended doses.

Children. It is more reasonable to children under 6 years to appoint medicament in the form of suspension. To children 3 years in case of impossible exact definition of a dose or the complicated swallowing medicament are aged more senior appoint in the form of suspension for oral administration.

Ability to influence speed of response at control of vehicles or other mechanisms. In case of emergence at use of medicament of dizziness, drowsiness, weakness, it is necessary to refrain from control of vehicles or other mechanisms.

Interaction

At simultaneous use of Pyrantelum with levamisole the toxicity of the last amplifies, it is not necessary to use medicament together with levimazoly.

should not apply Pyrantelum together with piperazin which shows antagonistic action to Pyrantelum.

Overdose

At administration of medicament in very high doses strengthening of its side effect, an ataxy are possible

.

At overdose — gastric lavage, control of the vital functions of an organism, symptomatic therapy.

in the presence of symptoms of antikholinesterazny action enter atropine.

Storage conditions

B origin

Characteristics
Active ingredients Pyrantelum
Amount of active ingredient 250 mg
Applicant Kusum Healthcare
Code of automatic telephone exchange P02CC01 Pyrantelum
Interaction with food It doesn't matter
Light sensitivity Not sensitive
Market status Generic-generic
Origin Chemical
Prescription status Without prescription
Primary packing blister
Producer KUSUM HELTKHKER PVT LTD
Quantity in packing 30 tablets (10 blisters on 3 pieces)
Release form tablets for internal use
Route of administration Oral
Sign Import
Storage temperature from 5 °C to 25 °C
Trade name Pyrantelum

Reviews Pyrantelum of the tab. of 250 mg No. 30

5 Rating 1 Reviews

Quality
Speed
Delivery
Performance
Price

Pyrantelum of the tab. of 250 mg No. 30

  • Product Code: 182927
  • In Stock

  • Ready to ship
  • $29.67


Related Products

Last Viewed

Модули для Opencart